|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Myopia | |||||
| Strabismus | |||||
| Esophoria | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Esotropia | |||||
| 3 | More general conditions related to this trial | ||||
| Cranial Nerve Diseases | |||||
| Eye Diseases | |||||
| Nervous System Diseases | |||||
| Ocular Motility Disorders | |||||
| 4 | Interventions listed in this trial | ||||
| Bifocal Spectacle Lenses | |||||
| 5 | Sponsors listed in this trial | ||||
| National Eye Institute (NEI) | |||||